Literature DB >> 22447955

Withdrawal of 'Xigris' from the market: old and new lessons.

Daniele Poole, Guido Bertolini, Silvio Garattini.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22447955     DOI： 10.1136/jech-2012-200977

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  3 in total

1.  Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.

Authors:  Barbara Ellen Jones; Jian Ying; Vanessa Stevens; Candace Haroldsen; Tao He; McKenna Nevers; Matthew A Christensen; Richard E Nelson; Gregory J Stoddard; Brian C Sauer; Peter M Yarbrough; Makoto M Jones; Matthew Bidwell Goetz; Tom Greene; Matthew H Samore
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

2.  A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo.

Authors:  Xiangting Ge; Zhiguo Feng; Tingting Xu; Beibei Wu; Hongjin Chen; Fengli Xu; Lili Fu; Xiaoou Shan; Yuanrong Dai; Yali Zhang; Guang Liang
Journal:  Drug Des Devel Ther       Date:  2016-06-30       Impact factor: 4.162

3.  Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial.

Authors:  Aparna Shukla
Journal:  Indian J Anaesth       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.